CLEC12A and acute myeloid leukemia: This study offers a comprehensive analysis of the most relevant AML surface antigenic markers —CD123, CD33, ADGRE2, CLL-1, TIM-3, CD70, among others— along with their expression patterns across key cell types, including leukemic blasts, leukemic stem cells, hematopoietic stem cells and progenitors, adult blood cells, and other tissues.